83
Views
14
CrossRef citations to date
0
Altmetric
Review

Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents

&
Pages 457-468 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David Allen, Dustin Wilson, Richard Drew & John Perfect. (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Review of Anti-infective Therapy 13:6, pages 787-798.
Read now

Articles from other publishers (13)

Mauricette Michallet, Jean el Cheikh, Raoul Herbrecht, Ibrahim Yakoub-Agha, Denis Caillot & Jean-Pierre Gangneux. (2022) Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study. BMC Infectious Diseases 22:1.
Crossref
Carlos Solano, Monica Slavin, Alissa J. Shaul, David I. Marks, Catherine Cordonnier, Oliver A. Cornely, Antonio Pagliuca, Lael Cragin, Isidro Jarque, Carolina Garcia-Vidal, Sonja Sorensen, David J. Vanness, Claudie Charbonneau, Jon Andoni Barrueta, Carmen Peral, Marina De Salas-Cansado & Eric J. Bow. (2017) Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Mycoses 60:2, pages 79-88.
Crossref
Anne-Marie Chaftari, Ray Y. Hachem, Elizabeth Ramos, Christelle Kassis, Marcela Campo, Ying Jiang, Randall A. Prince, Weiqun Wang & Issam I. Raad. (2012) Comparison of Posaconazole Versus Weekly Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in Hematopoietic Stem-Cell Transplantation. Transplantation 94:3, pages 302-308.
Crossref
Errol Reiss, H. Jean Shadomy & G. Marshall LyonIIIIII. 2011. Fundamental Medical Mycology. Fundamental Medical Mycology 75 106 .
Paul A. Mann, Paul M. McNicholas, Andrew S. Chau, Reena Patel, Cara Mendrick, Andrew J. Ullmann, Oliver A. Cornely, Hernando Patino & Todd A. Black. (2009) Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species . Antimicrobial Agents and Chemotherapy 53:12, pages 5026-5034.
Crossref
Pasquale De Bellis. (2009) Conclusions. Drugs 69:Supplement 1, pages 99-102.
Crossref
Dorothy McCoy, Daryl D. DePestel & Peggy L. Carver. (2012) Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29:11, pages 1306-1325.
Crossref
J Styczynski & L Gil. (2008) Prevention of infectious complications in pediatric HSCT. Bone Marrow Transplantation 42:S2, pages S77-S81.
Crossref
Dorothy Surowiec, Daryl D. DePestel & Peggy L. Carver. (2012) Concurrent Administration of Sirolimus and Voriconazole: A Pilot Study Assessing Safety and Approaches to Appropriate Management. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:6, pages 719-729.
Crossref
Warren Schonfeld, J. Wang Cheng, Kuo B. Tong & Raafat Seifeldin. (2008) Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Clinical Therapeutics 30:5, pages 964-973.
Crossref
Satoshi Hashino, Lena Morita, Mutsumi Takahata, Masahiro Onozawa, Masao Nakagawa, Takahito Kawamura, Fumie Fujisawa, Kaoru Kahata, Koh Izumiyama, Masakatsu Yonezumi, Koji Chiba, Takeshi Kondo & Masahiro Asaka. (2007) Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation. International Journal of Hematology 87:1, pages 91-97.
Crossref
Isidro Jarque & Miguel A. Sanz. (2007) Indicaciones actuales de voriconazol en pacientes onco-hematológicos. Revista Iberoamericana de Micología 24:3, pages 213-216.
Crossref
Jan Styczyński & Lidia Gil. (2007) Strategies for prevention of infectious complications in children after HSCT in relation to type of transplantation and GVHD occurrence. Reports of Practical Oncology & Radiotherapy 12:3, pages 149-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.